Hemostats For Wound Closure Market

Hemostats For Wound Closure Market


Historically wound types remain the same over the ages with only a slight exception being the emergence of femoral punctures associated with catheterization procedures. But with the advent of newer technologies the practice of closing those wounds are changed.

These new products are commonly available on hospitals & trauma centers and have wide range of usage area. Among them Hemostat has become a very popular tool to be used as wound closure material with its excellent properties. When applied to a wound, quickly absorbs blood and other body fluids, transforms into a gel to seal the wound with a protective transparent layer, actively aids in stopping bleeding, and creates an environment for wound healing.

Treatment of damaged cardiac tissue in patients with high bleeding tendency can be very challenging. In this category of surgery Hemostat proved to be a very effective with the combination of collagen sponge for the management of a myocardial wound

Topical hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

Hemostats for Wound Closure: Drivers and Restraints

Wound closure has become a very frequent clinical practice which is growing very rapidly. The sophisticated procedures ensure rapid cessation of blood loss, prompt closure, strong adhesion of wound edges, tight sealing, reduced scarring, reduced risk of infection and more rapid healing. There is a pool of patients throughout the world which makes the market of this product is very lucrative. As the price is also very reasonable so acceptance of this product is gradually progressing.

On the other hand some reports come which could restrict the growth. Surgical staples are emerging as the most useful tool on this wound closure segment. Also the market of suture which is there traditionally remains constant if not growing to some parts of the world. Few reports also suggested that patients may suffer with irritation, heat inflammation or redness on skin when hemostat are applied, though its not clear the exact reason for these.

As the market is growing and price is low, so tough competitions will prevail in this segment too.

Hemostats for Wound Closure: Segmentation

Global market for wound closure products consist of hemostat are mainly driven the use of Fibrin which is the combination of thrombin & fibrinogen. Also collagen finds it use as hemostat though it still needs the approval of USFDA.
  • Thrombin based Hemostats
  • Combination Hemostats
  • Oxidized Regenerated Cellulose Hemostats
  • Gelatin Hemostats
  • Collagen based Hemostats
Hemostats for Wound Closure: Overview

With the rapid technological advancement in healthcare industry the Hemostats is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Hemostats for Wound Closure: Region-wise Outlook

Geographically, the wound closure products market has been segmented into seven major geographical regions which include North America, Eastern Europe, Western Europe, Asia Pacific exclude Japan, Japan & Latin America, Middle east & Africa. North America contribute the most in this market followed by Europe. With the new product approvals, change in regulatory policies encourages, patient acceptance helps the market to grow. Asia Pacific & Japan pose good growth potential too for wound closure products specially Hemostat.

Hemostats for Wound Closure: Key Players

Wound closure product market is highly fragmented with presence of big & small companies. The market leaders in this area are Johnson & Johnson, Covidien, B. Braun, and 3M.

The report covers exhaustive analysis on:
  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
Competition & Companies involved
  • Technology
  • Value Chain
Regional analysis includes
  • North America (U.S., Canada)
  • Latin America (Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands,
  • Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:
  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.


1. Executive Summary
  1.1. Global Market Outlook
  1.2. Demand-side Trends
  1.3. Supply-side Trends
  1.4. Technology Roadmap Analysis
  1.5. Analysis and Recommendations
2. Market Overview
  2.1. Market Coverage / Taxonomy
  2.2. Market Definition / Scope / Limitations
3. Market Background
  3.1. Market Dynamics
    3.1.1. Drivers
    3.1.2. Restraints
    3.1.3. Opportunity
    3.1.4. Trends
  3.2. Scenario Forecast
    3.2.1. Demand in Optimistic Scenario
    3.2.2. Demand in Likely Scenario
    3.2.3. Demand in Conservative Scenario
  3.3. Opportunity Map Analysis
  3.4. Investment Feasibility Matrix
  3.5. PESTLE and Porter’s Analysis
  3.6. Regulatory Landscape
    3.6.1. By Key Regions
    3.6.2. By Key Countries
  3.7. Regional Parent Market Outlook
4. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast, 2022-2032
  4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
  4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
    4.2.1. Y-o-Y Growth Trend Analysis
    4.2.2. Absolute $ Opportunity Analysis
5. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
  5.1. Introduction / Key Findings
  5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
  5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
    5.3.1. Thrombin Based Hemostats
    5.3.2. Combination Hemostats
    5.3.3. Oxidized Regenerated Hemostats
    5.3.4. Cellulose Based Hemostats
    5.3.5. Gelatin Based Hemostats
    5.3.6. Collagen Based Hemostats
  5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
  5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By End User
  6.1. Introduction / Key Findings
  6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
  6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
    6.3.1. Hospitals
    6.3.2. Ambulatory Surgical Centers
    6.3.3. Specialty Clinics
  6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
  6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Region
  7.1. Introduction
  7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
  7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
    7.3.1. North America
    7.3.2. Latin America
    7.3.3. Europe
    7.3.4. East Asia
    7.3.5. South Asia & Pacific
    7.3.6. MEA
  7.4. Market Attractiveness Analysis By Region
8. North America Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    8.2.1. By Country
      8.2.1.1. U.K.
      8.2.1.2. Canada
    8.2.2. By Product Type
    8.2.3. By End User
  8.3. Market Attractiveness Analysis
    8.3.1. By Country
    8.3.2. By Product Type
    8.3.3. By End User
  8.4. Key Takeaways
9. Latin America Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    9.2.1. By Country
      9.2.1.1. Brazil
      9.2.1.2. Mexico
      9.2.1.3. Rest of Latin America
    9.2.2. By Product Type
    9.2.3. By End User
  9.3. Market Attractiveness Analysis
    9.3.1. By Country
    9.3.2. By Product Type
    9.3.3. By End User
  9.4. Key Takeaways
10. Europe Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    10.2.1. By Country
      10.2.1.1. Germany
      10.2.1.2. U.K.
      10.2.1.3. France
      10.2.1.4. Spain
      10.2.1.5. Italy
      10.2.1.6. Rest of Europe
    10.2.2. By Product Type
    10.2.3. By End User
  10.3. Market Attractiveness Analysis
    10.3.1. By Country
    10.3.2. By Product Type
    10.3.3. By End User
  10.4. Key Takeaways
11. East Asia Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    11.2.1. By Country
      11.2.1.1. China
      11.2.1.2. Japan
      11.2.1.3. South Korea
    11.2.2. By Product Type
    11.2.3. By End User
  11.3. Market Attractiveness Analysis
    11.3.1. By Country
    11.3.2. By Product Type
    11.3.3. By End User
  11.4. Key Takeaways
12. South Asia & Pacific Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    12.2.1. By Country
      12.2.1.1. India
      12.2.1.2. Thailand
      12.2.1.3. Indonesia
      12.2.1.4. Malaysia
      12.2.1.5. Singapore
      12.2.1.6. Australia
      12.2.1.7. New Zealand
      12.2.1.8. Rest of South Asia & Pacific
    12.2.2. By Product Type
    12.2.3. By End User
  12.3. Market Attractiveness Analysis
    12.3.1. By Country
    12.3.2. By Product Type
    12.3.3. By End User
  12.4. Key Takeaways
13. MEA Hemostats For Wound Closure Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    13.2.1. By Country
      13.2.1.1. GCC Countries
      13.2.1.2. South Africa
      13.2.1.3. Israel
      13.2.1.4. Rest of MEA
    13.2.2. By Product Type
    13.2.3. By End User
  13.3. Market Attractiveness Analysis
    13.3.1. By Country
    13.3.2. By Product Type
    13.3.3. By End User
  13.4. Key Takeaways
14. Key Countries Hemostats For Wound Closure Market Analysis
  14.1. U.K.
    14.1.1. Pricing Analysis
    14.1.2. Market Share Analysis, 2021
      14.1.2.1. By Product Type
      14.1.2.2. By End User
  14.2. Canada
    14.2.1. Pricing Analysis
    14.2.2. Market Share Analysis, 2021
      14.2.2.1. By Product Type
      14.2.2.2. By End User
  14.3. Brazil
    14.3.1. Pricing Analysis
    14.3.2. Market Share Analysis, 2021
      14.3.2.1. By Product Type
      14.3.2.2. By End User
  14.4. Mexico
    14.4.1. Pricing Analysis
    14.4.2. Market Share Analysis, 2021
      14.4.2.1. By Product Type
      14.4.2.2. By End User
  14.5. Germany
    14.5.1. Pricing Analysis
    14.5.2. Market Share Analysis, 2021
      14.5.2.1. By Product Type
      14.5.2.2. By End User
  14.6. U.K.
    14.6.1. Pricing Analysis
    14.6.2. Market Share Analysis, 2021
      14.6.2.1. By Product Type
      14.6.2.2. By End User
  14.7. France
    14.7.1. Pricing Analysis
    14.7.2. Market Share Analysis, 2021
      14.7.2.1. By Product Type
      14.7.2.2. By End User
  14.8. Spain
    14.8.1. Pricing Analysis
    14.8.2. Market Share Analysis, 2021
      14.8.2.1. By Product Type
      14.8.2.2. By End User
  14.9. Italy
    14.9.1. Pricing Analysis
    14.9.2. Market Share Analysis, 2021
      14.9.2.1. By Product Type
      14.9.2.2. By End User
  14.10. China
    14.10.1. Pricing Analysis
    14.10.2. Market Share Analysis, 2021
      14.10.2.1. By Product Type
      14.10.2.2. By End User
  14.11. Japan
    14.11.1. Pricing Analysis
    14.11.2. Market Share Analysis, 2021
      14.11.2.1. By Product Type
      14.11.2.2. By End User
  14.12. South Korea
    14.12.1. Pricing Analysis
    14.12.2. Market Share Analysis, 2021
      14.12.2.1. By Product Type
      14.12.2.2. By End User
  14.13. India
    14.13.1. Pricing Analysis
    14.13.2. Market Share Analysis, 2021
      14.13.2.1. By Product Type
      14.13.2.2. By End User
  14.14. Thailand
    14.14.1. Pricing Analysis
    14.14.2. Market Share Analysis, 2021
      14.14.2.1. By Product Type
      14.14.2.2. By End User
  14.15. Indonesia
    14.15.1. Pricing Analysis
    14.15.2. Market Share Analysis, 2021
      14.15.2.1. By Product Type
      14.15.2.2. By End User
  14.16. Malaysia
    14.16.1. Pricing Analysis
    14.16.2. Market Share Analysis, 2021
      14.16.2.1. By Product Type
      14.16.2.2. By End User
  14.17. Singapore
    14.17.1. Pricing Analysis
    14.17.2. Market Share Analysis, 2021
      14.17.2.1. By Product Type
      14.17.2.2. By End User
  14.18. Australia
    14.18.1. Pricing Analysis
    14.18.2. Market Share Analysis, 2021
      14.18.2.1. By Product Type
      14.18.2.2. By End User
  14.19. New Zealand
    14.19.1. Pricing Analysis
    14.19.2. Market Share Analysis, 2021
      14.19.2.1. By Product Type
      14.19.2.2. By End User
  14.20. GCC Countries
    14.20.1. Pricing Analysis
    14.20.2. Market Share Analysis, 2021
      14.20.2.1. By Product Type
      14.20.2.2. By End User
  14.21. South Africa
    14.21.1. Pricing Analysis
    14.21.2. Market Share Analysis, 2021
      14.21.2.1. By Product Type
      14.21.2.2. By End User
  14.22. Israel
    14.22.1. Pricing Analysis
    14.22.2. Market Share Analysis, 2021
      14.22.2.1. By Product Type
      14.22.2.2. By End User
15. Market Structure Analysis
  15.1. Competition Dashboard
  15.2. Competition Benchmarking
  15.3. Market Share Analysis of Top Players
    15.3.1. By Regional
    15.3.2. By Product Type
    15.3.3. By End User
16. Competition Analysis
  16.1. Competition Deep Dive
    16.1.1. Johnson & Johnson Services, Inc.
      16.1.1.1. Overview
      16.1.1.2. Product Portfolio
      16.1.1.3. Profitability by Market Segments
      16.1.1.4. Sales Footprint
      16.1.1.5. Strategy Overview
        16.1.1.5.1. Marketing Strategy
    16.1.2. Baxter
      16.1.2.1. Overview
      16.1.2.2. Product Portfolio
      16.1.2.3. Profitability by Market Segments
      16.1.2.4. Sales Footprint
      16.1.2.5. Strategy Overview
        16.1.2.5.1. Marketing Strategy
    16.1.3. B. Braun Melsungen AG
      16.1.3.1. Overview
      16.1.3.2. Product Portfolio
      16.1.3.3. Profitability by Market Segments
      16.1.3.4. Sales Footprint
      16.1.3.5. Strategy Overview
        16.1.3.5.1. Marketing Strategy
    16.1.4. Pfizer Inc.
      16.1.4.1. Overview
      16.1.4.2. Product Portfolio
      16.1.4.3. Profitability by Market Segments
      16.1.4.4. Sales Footprint
      16.1.4.5. Strategy Overview
        16.1.4.5.1. Marketing Strategy
    16.1.5. Integra LifeSciences
      16.1.5.1. Overview
      16.1.5.2. Product Portfolio
      16.1.5.3. Profitability by Market Segments
      16.1.5.4. Sales Footprint
      16.1.5.5. Strategy Overview
        16.1.5.5.1. Marketing Strategy
    16.1.6. Advanced Medical Solutions Group plc.
      16.1.6.1. Overview
      16.1.6.2. Product Portfolio
      16.1.6.3. Profitability by Market Segments
      16.1.6.4. Sales Footprint
      16.1.6.5. Strategy Overview
        16.1.6.5.1. Marketing Strategy
    16.1.7. C. R. Bard, Inc.
      16.1.7.1. Overview
      16.1.7.2. Product Portfolio
      16.1.7.3. Profitability by Market Segments
      16.1.7.4. Sales Footprint
      16.1.7.5. Strategy Overview
        16.1.7.5.1. Marketing Strategy
    16.1.8. Cresilon
      16.1.8.1. Overview
      16.1.8.2. Product Portfolio
      16.1.8.3. Profitability by Market Segments
      16.1.8.4. Sales Footprint
      16.1.8.5. Strategy Overview
        16.1.8.5.1. Marketing Strategy
    16.1.9. Medtronic
      16.1.9.1. Overview
      16.1.9.2. Product Portfolio
      16.1.9.3. Profitability by Market Segments
      16.1.9.4. Sales Footprint
      16.1.9.5. Strategy Overview
        16.1.9.5.1. Marketing Strategy
    16.1.10. Tissuemed Ltd
      16.1.10.1. Overview
      16.1.10.2. Product Portfolio
      16.1.10.3. Profitability by Market Segments
      16.1.10.4. Sales Footprint
      16.1.10.5. Strategy Overview
        16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings